Lipid-Lowering Effects of Inclisiran in Statin- or PCSK9i Monoclonal Antibody-Intolerant Individuals

Scritto il 18/09/2026
da Ashish Sarraju

No abstract

J Am Heart Assoc. 2026 Sep 18:e048727. doi: 10.1161/JAHA.125.048727. Online ahead of print.

NO ABSTRACT

PMID:42757932 | DOI:10.1161/JAHA.125.048727